default author photo

Joanna Kopecka

University of Turin

SCHOLARLY PAPERS

3

DOWNLOADS

85

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

New Dimension of Ciprofloxacin Hybrids: Synthesis, Characterization and Anticancer Evaluation of Newly C3-Modified Ciprofloxacin Derivatives

Number of pages: 36 Posted: 05 Jun 2025
Polish Academy of Sciences, Polish Academy of Sciences, affiliation not provided to SSRN, University of Turin, University of Turin, Università degli Studi di Bari “Aldo Moro” (UNIBA), affiliation not provided to SSRN, affiliation not provided to SSRN, University of Siena, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 39

Abstract:

Loading...

Ciprofloxacin-hybrids, Peptidomimetics, Passerini reaction, Anticancer activity, Chemosensitization activity, P-glycoprotein interactions, in vitro toxicity

2.

Self-assembling hyaluronic acid octasaccharide-lipid conjugate for CD44-mediated targeted drug delivery in cancer cells

Number of pages: 24 Posted: 19 Jun 2026
University of Turin, affiliation not provided to SSRN, University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, University of Turin, affiliation not provided to SSRN and University of Turin
Downloads 24

Abstract:

Loading...

hyaluronic acid, nanoassemblies, doxorubicin, CD44 receptor

3.

Increasing Membrane Polyunsaturated Fatty Acids Sensitizes Non-Small Cell Lung Cancer to Anti-Pd-1/Pd-L1 Immunotherapy

Number of pages: 128 Posted: 21 May 2024
affiliation not provided to SSRN, affiliation not provided to SSRN, University of Turin, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Turin and University of Turin
Downloads 22

Abstract:

Loading...

non-small cell lung cancer, immune checkpoints inhibitors, phospholipidome, letrozole, docosahexaenoic acid